FundedIQ
Health Care

Aseptuva: Funding, Investors & Team (Sep 2026)

We are creating a number of Class II (a, b) medical devices for in-situ cleaning of catheters and tubes implanted into patients both within and outside of an intensive care unit. Our automated and focused solution works to prevent hospital secondary infections like VAP, CLABSI, etc., lessening the load on healthcare personnel and enhancing patient experience by reducing length of stay and avoiding unnecessary expenses.

aseptuva.ch LinkedIn Winterthur, Switzerland 1-10 employees
Health Care Medical Medical Device
Total raised
$60k
Rounds
1
Latest
Undisclosed round
Feb 2023

Aseptuva has raised $60k across 1 funding round on record, the most recent an undisclosed round of $60k announced in Feb 2023.

That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

Aseptuva Company Profile and Key Stats

Total funding raised
$60k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$60k in Feb 2023
Employees
1-10
reported band
Headquarters
Winterthur, Switzerland

Latest funding round on record: Feb 2023.

Aseptuva Funding Rounds

Date
Round
Amount
Undisclosed round
$60k

Aseptuva Founders and Leadership Team

Name
Role
Contact
Henry Twerenbold
CEO

No contact details are on record for this team yet.

Aseptuva Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
879
$3.8M

Aseptuva's latest round of $60k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Aseptuva in Health Care and Winterthur

Companies Similar to Aseptuva

MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.

Undisclosed round $110k

CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…

Series E $100M

Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…

Undisclosed round $190k

NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…

Series B $33.6M

UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…

Undisclosed round $130k

Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…

Undisclosed round $2.6M
Seed

Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…

Undisclosed round $6.0M

Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…

Undisclosed round $1.0M

Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…

Undisclosed round $150k

Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…

Undisclosed round $8.7M

Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…

Undisclosed round $4.5M

Aseptuva Funding FAQs

What does Aseptuva do?

We are creating a number of Class II (a, b) medical devices for in-situ cleaning of catheters and tubes implanted into patients both within and outside of an intensive care unit. Our automated and focused solution works to prevent hospital secondary infections like VAP, CLABSI, etc., lessening the load on healthcare personnel and enhancing patient experience by reducing length of stay and avoiding unnecessary expenses.

How much funding has Aseptuva raised?

Aseptuva has raised $60k across 1 round on record. The most recent is an undisclosed round of $60k announced in Feb 2023.

When did Aseptuva last raise funding?

Aseptuva's most recent funding round on record is an undisclosed round of $60k, announced in Feb 2023.

Who is the CEO of Aseptuva?

Henry Twerenbold is listed as CEO at Aseptuva.

Where is Aseptuva headquartered?

Aseptuva is based in Winterthur, Zurich, Switzerland.

How many employees does Aseptuva have?

Aseptuva is in the 1-10 employee band.

How does Aseptuva's funding compare to other Health Care startups?

Aseptuva's latest round of $60k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Aseptuva Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aseptuva is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.